In vitro and in vivo evaluation of novel ligands for radioimmunotherapy

This publication has 27 references indexed in Scilit:

• Synthesis and Evaluation of Novel Macrocyclic and Acyclic Ligands as Contrast Enhancement Agents for Magnetic Resonance Imaging
  Journal of Medicinal Chemistry, 2006
• Comparative in Vivo Behavior Studies of Cyclen-Based Copper-64 Complexes: Regioselective Synthesis, X-ray Structure, Radiochemistry, log P, and Biodistribution
  Journal of Medicinal Chemistry, 2004
• Solution Dynamics and Stability of Lanthanide(III) (S)-2-(p-Nitrobenzyl)DOTA Complexes
  Inorganic Chemistry, 2004
• Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid for radiolabeling proteins
  Nuclear Medicine and Biology, 2003
• The Development of the α-Particle Emitting Radionuclides ²¹²Bi and ²¹³Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
  Chemical Reviews, 2001
• Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides
  Nuclear Medicine and Biology, 2001
• Clinical radioimmunotherapy
  Seminars in Radiation Oncology, 2000
• Criteria for the Selection of Radionuclides for Targeting Nuclear Antigens for Cancer Radioimmunotherapy
  Cancer Biotherapy & Radiopharmaceuticals, 1996
• The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
• Lead(II) and bismuth(III) complexes of the polyazacycloalkane-N-acetic acids nota, dota, and teta
  Journal of the Chemical Society, Chemical Communications, 1989